U-PMCB

Q:PMCB - PHARMACYTE BIOTECH INC - https://www.pharmacytebiotech.com

11:58:39 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
PMCB - Q	0.1	0.5756	·	0.60	17.9	0.5878	-0.0023	-0.4	14.2	6	53	0.5703 0.60 0.5703	1.51 0.5501	11:33:17	Nov 25	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Up -- UPC Restricted: No
Financial Status: Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Portfolio

Recent Trades - Last 10 of 53

More trades...

Time ET	Ex	Price	Change	Volume
11:33:17	Q	0.5878	-0.0023	100
11:31:40	Q	0.5994	0.0093	98
11:31:04	Q	0.5759	-0.0142	98
11:31:04	Q	0.5878	-0.0023	112
11:30:29	Q	0.588	-0.0021	250
11:29:40	Q	0.588	-0.0021	100
11:20:01	Q	0.5999	0.0098	16
11:20:01	Q	0.5999	0.0098	1
11:18:02	Q	0.5753	-0.0148	2
11:15:37	Q	0.59	-0.0001	5

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2025-11-25 09:15	U:PMCB	News Release200	PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
2025-09-02 09:20	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
2025-08-20 09:15	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
2025-08-18 09:15	U:PMCB	News Release200	PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

Date ET

Symbol

Type

Headline

2025-11-25 09:15

U:PMCB

News Release

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

2025-09-02 09:20

U:PMCB

News Release

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications